Diametric Capital’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Diametric Capital’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-44,449	Closed	-$228K	–	385
2022 Q3	$228K	Buy	44,449 +26,949	+154%	+$169K	0.11%	208
2022 Q2	$110K	Buy	+17,500	New	+$58.9K	0.08%	222

Other funds holding FSTX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Diametric Capital's FSTX Position: Q4 2022 in Review

Diametric Capital sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2022, closing a stake of 44,449 shares — an estimated $228K sold.

Diametric Capital first reported a position in FSTX in Q2 2022 and held it in 2 quarters. The position peaked at $228K in Q3 2022. 59 funds tracked by Wall St. Rank hold FSTX as of Q4 2022.

Diametric Capital reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Diametric Capital sold 44,449 F-star Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $228K.
Diametric Capital first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Diametric Capital's F-star Therapeutics, Inc. Common Stock position peaked at $228K in Q3 2022.
59 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Diametric Capital's 13F filing for Q4 2022, filed 29 Mar 2023.